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Abstract: This study develops a spectroscopic algorithm for detection of 
cervical high grade squamous intraepithelial lesions (HSILs). We collected 
reflectance and fluorescence spectra with the quantitative spectroscopy 
probe to measure nine spectroscopic parameters from 43 patients 
undergoing standard colposcopy with directed biopsy. We found that there 
is improved accuracy for distinguishing HSIL from non-HSIL (low grade 
SIL and normal tissue) when we “normalized” spectroscopy parameters by 
dividing the values extracted from each clinically determined suspicious site 
by the corresponding value extracted from a clinically normal squamous site 
from the same patient. The “normalized” scattering parameter (A) at 700nm, 
best distinguished HSIL from non-HSIL with sensitivity and specificity of 
89% and 79% suggesting that a simple, monochromatic instrument 
measuring only A may accurately detect HSIL. 
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The main target of the clinical management of women with suspected squamous 
intraepithelial lesions (SIL) is the accurate diagnosis of precancerous changes, specifically 
high grade SIL (HSIL). The current clinical standard for diagnosis of HSIL is colposcopy, a 
procedure that involves visual inspection and biopsy of at-risk tissue, followed by 
histopathological diagnosis. The diagnostic accuracy of colposcopy greatly depends on the 
physician’s expertise and even when conducted by experts, is subject to significant diagnostic 
variability [1]. Spectroscopy is a technique that may reduce the interobserver disagreement of 
colposcopy and improve its diagnostic accuracy by diagnosing HSIL in an objective manner. 
The effectiveness of spectroscopic techniques, specifically reflectance and fluorescence, for in 
vivo diagnosis of HSIL has been extensively evaluated [2–16] These studies demonstrate the 
potential of spectroscopy to improve the effectiveness of disease detection [17]. 
The spectroscopic diagnosis of cervical dysplasia is based on the contrast in tissue spectra 
caused by loss of differentiation of the epithelial cells [18], degradation and reorganization of 
stromal collagen by matrix metalloproteinase activity [19,20], increased metabolic activity, 
and angiogenesis [21]. Tissue spectroscopy is not only affected by disease, but also by age 
[15,22–26], menopausal status [15,23–27], time after the application of acetic acid [12], and 
normal variations in cervical anatomy [6,23,28,29]. 
Historically, spectroscopic studies have included clinically normal squamous sites, either 
non-biopsied or histopathologically confirmed, in the validation set for diagnosing HSILs 
[5,6,8,10,28]. Mourant et al. [11,14] and Georgakoudi et al. [9] noted an apparent increase in 
diagnostic power when clinically normal tissues were included in the validation set. Similarly, 
Freeberg et al. [23] observed that tissue type influences both reflectance and fluorescence 
measurements. 
In a recent study by our laboratory, we demonstrated that underlying differences in tissue 
anatomy can have a confounding effect on diagnostic spectral algorithms [29]. Normal 
transformation zone of the cervix, the area where the vast majority of HSILs are found [30], is 
anatomically, histologically, and spectroscopically different from the normal squamous 
mucosa. As the vast majority of the HSILs are found in the transformation zone, the spectral 
differences between normal squamous mucosa and HSIL are largely due to normal anatomical 
differences. Based on the findings of this study, a common practice of including clinically 
normal squamous sites into the data set which is used to develop or evaluate the performance 
of the algorithm for detection of HSIL is a confounding artifact that artificially increases 
performance values with respect to the key differentiation to be made, namely distinguishing 
HSILs from clinically suspicious non-HSILs. The data in this study demonstrated the 
confounding influence of including clinically normal squamous sites not only affects the 
performance levels but also the number of specific spectroscopic parameters that can be used 
in the diagnostic algorithm. The affected parameters included those describing the scattering, 
absorption, and fluorescence properties of tissue. In order to properly evaluate the accuracy of 
clinical disease detection, spectroscopic data must be analyzed within the appropriate 
anatomical context. 
The aim of the present study was to develop an algorithm for detection of HSILs free of 
the confounding effect of cervical anatomy. We studied patients undergoing colposcopic 
examination and used reflectance and fluorescence spectroscopy to differentiate HSILs from 
non-HSILs among abnormal sites identified by the clinician as needing biopsy. Physical 
models were used to fit the spectra and extract parameters related to tissue morphology and 
biochemistry. We investigated the effect of per-patient parameter normalization on diagnostic 
performance as well as the effect of normal anatomical variation within the transformation 
zone, the glandular content, on the extracted spectroscopy parameters. The spectroscopy 
parameters were then used to develop a spectroscopic diagnostic algorithm to distinguish 
HSILs from non-HSILs. 
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2.1. Data collection 
Details of data collection and spectroscopic analysis of a cervical data set used in this study 
were previously described by Mirkovic et al. [29]. Briefly, the clinical in vivo study was 
conducted at the Boston Medical Center and involved 43 patients undergoing colposcopic 
evaluation following an abnormal Pap smear. For each patient, reflectance and fluorescence 
spectra were collected from a colposcopically normal squamous (CNSQ) site as well as 
colposcopically abnormal sites using a fiber optic based clinical device developed by our 
laboratory known as the Fast Excitation Emission Matrix (FastEEM). The instrument and the 
calibration procedures have been previously described. 
20 After the application of acetic acid 
(5% solution) to the cervix during colposcopy, the probe which samples an area of tissue ~1 
mm in diameter was brought into gentle contact with the tissue. The reflectance and 
fluorescence spectra were acquired in approximately three seconds. Two to three 
measurements were acquired for each tissue site. Colposcopically abnormal sites were then 
biopsied and evaluated by histopathology. Clinically normal squamous sites were not 
biopsied. 
2.2. Histopathology 
Each biopsy specimen underwent standard histopathological processing. In order to minimize 
inter-observer diagnostic variability, hematoxylin and eosin stained tissue sections were 
evaluated independently by three experienced pathologists (CC, ADLM, TD) using standard 
diagnostic criteria. Consensus diagnosis (agreement between two of the three pathologists) 
was used as the diagnostic gold standard. Each biopsied site was classified as either HSIL or 
non-HSIL (negative for SIL or low grade squamous intraepithelial lesion, LSIL). 
All histologic specimens were further examined by a single pathologist (CC) for the 
absence or presence of features consistent with the transformation zone. If the stroma (the 
connective tissue underlying the epithelium) of a particular site was visible, we further 
performed a qualitative assessment of its glandular content. Each site was classified as having 
either a significant glandular content or a minimal glandular content based on whether the 
ratio of the area occupied by glands to area occupied by stroma was ≥0.25 or <0.25. Finally, 
the average epithelial thickness was measured with Zeiss Axio Imager 2.0.0.0. software and 
defined by an average value of three measurements across the surface epithelium. 
2.3. Spectral data analysis 
Four patients were excluded due to instrument malfunctions during measurement (CCD 
camera overheat, probe damage). Raw spectra for each set of measurements were examined 
and those with poor overlap between repeat measurements were excluded. We excluded 3 
study sites for which all sets in a measurement were inconsistent (>10% average standard 
deviation between measurements), as well as 4 sites for which the tissue started bleeding due 
to probe contact. 
We used physically-based models to extract the spectroscopy parameters from the tissue 
reflectance and fluorescence spectra. The reflectance spectra were analyzed using the diffuse 
scattering model developed by Zonios et al. [31], and tissue fluorescence emission spectra 
were analyzed by the photon-migration model developed by Muller et al. [32]. The details of 
spectral data analysis were further described by Mirkovic et al. [29]. As a result, we derived 
nine spectroscopic parameters from modeling tissue reflectance and fluorescence: scattering 
parameters (A  [mm
−1],  B, and C  [mm
−1]), hemoglobin concentration Hb [mg/ml], oxygen 
saturation  α,  effective  blood  vessel  radius  bvr  [mm],  concentration  of  beta-carotene  β-car 
[mg/ml], and the fractional contributions of collagen and NADH in the intrinsic fluorescence 
(Coll and NADH, respectively). We note that the A parameter is equivalent to the reduced 
scattering coefficient at 700 nm. 
To identify changes in spectroscopic parameters due to disease, we studied the values of 
extracted spectroscopy parameters from clinically  suspicious sites. During colposcopy, 
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normal tissue. We evaluated whether a similar procedure would be useful for a spectroscopic-
based diagnostic method. Specifically, we divided the spectroscopy parameters extracted from 
each clinically suspicious site by the values of the corresponding spectroscopy parameters 
extracted from a CNSQ site collected from the same patient. Parameters derived from this 
procedure are subsequently referred to as normalized spectroscopy parameters. 
Normalized spectroscopy parameters were correlated to the histopathology diagnosis for 
all data collected from clinically suspicious sites. A two-sided Wilcoxon Rank Sum test was 
used to test the hypothesis that the extracted normalized spectroscopic parameter distributions 
of HSIL and non-HSIL were different. A p-value of <0.05 was considered significant. The 
spectral algorithms were developed using logistic regression models to identify the significant 
spectroscopic parameters providing the diagnostic information. The likelihood ratio test was 
used to assess the significance of each of the parameters in the logistic regression model. 
21 A 
p-value <0.05 was considered to be significant. Leave-one-out cross-validation (LCV) was 
used to construct receiver-operator characteristic (ROC) curves for the spectral algorithms. 
The discrimination ability was evaluated by the area under the ROC curve (AUC), as well as 
the sensitivity and specificity. In the following, we report a point on the ROC curve which is 
the shortest distance away from the point of perfect separation (100% sensitivity and 100% 
specificity) defined by 
 
22
min 1 1
100 100
sensitivity specificity      − +−        
  (1) 
We refer to this point whenever we quote sensitivity and specificity values. 
To study the effect of tissue glandular content on the spectroscopy parameters, we divided 
non-HSIL sites into two groups: 1) non-HSIL sites with a gland-to-stroma ratio of <0.25 (non-
GS sites), and 2) non-HSIL sites with gland-to-stroma ratio of ≥0.25 (GS sites), and compared 
them to all HSIL sites by using the statistical methods (two-sided Wilcoxon Rank Sum test 
and LCV and logistic regression) described above. 
3. Results 
3.1. Data set 
As shown in Table 1, our data set consisted of 33 CNSQ sites, which were not biopsied, and 
51 clinically suspicious biopsied sites, out of which histopathology determined that 9 sites 
(from 6 patients) were HSILs and 42 sites were non-HSIL (30 sites negative for SIL from 19 
patients and 12 LSILs from 11 patients). We emphasize that the non-HSIL sites in our data set 
do not include the 33 CNSQ sites. The patient age for this data set ranges from 18 to 47 years, 
and the mean patient age is 26 ± 7.5 years. 
Table 1. Data set
a 
Clinical Category  Histology Category  No. of Sites 
Normal (CNSQ)  Not biopsied  33 
Suspicious 
non-HSIL 
Negative for SIL  30 
LSIL  12 
HSIL  9 
aClinically normal squamous, CNSQ; squamous intraepithelial lesions. 
SIL; high grade SIL, HSIL; low grade SIL, LSIL.
 
3.2. Microscopic characterization 
Histopathological evaluation confirmed that 36 of 51 biopsied sites were from the 
transformation zone. Fifteen sites could not be histologically confirmed as transformation 
zone (e.g., stroma was not visible on the histology slides to ensure full assessment or 
glandular elements were not present). All of the HSIL sites, except one for which stroma was 
not visible, were confirmed to be from the transformation zone. 
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glandular content (gland-to-stroma ratio of ≥0.25) was found in 5/8 (62.5%) of HSIL sites 
compared to 13/34 (38%) of non-HSIL sites, however this difference was not significant by 
Wilcoxon ransum test. There was no significant difference in epithelial thickness for HSIL 
and non-HSIL sites (171 ± 50 and 250 ± 124 μm, respectively). 
Table 2. Description of glandularity for non-HSIL and HSIL sites 
Group 
Glandular content (gland-to-stroma ratio) 
≥0.25 (GS)  <0.25 (non-GS)  Could not be evaluated 
non-HSIL  13  21  8 
HSIL  5  3  1 
 
Fig. 1. Discrimination of HSIL from non-HSIL among clinically suspicious sites. Boxplots of 
normalized (a) A  parameter  (reduced  scattering  coefficient  at  700nm),  (b)  α  (oxygen 
saturation), (c) bvr (blood vessel radius), (d) Hb (hemoglobin concentration), (e) Coll 
(fractional contribution of collagen to intrinsic fluorescence); (f) Receiver operator 
characteristic curve for the diagnostic algorithm (normalized A parameter only). Box plots: 
median (horizontal line within the box), upper and lower quartiles (upper and lower edges of 
the box, respectively), extent of the data (whiskers), and outliers (crosses, data points that are 
more than 1.5 times the interquartile range below the lower quartile or above the upper 
quartile). 
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To assess the potential clinical impact of our technique, it is essential to evaluate its success in 
differentiating HSIL from non-HSIL sites among clinically suspicious sites, most of which are 
found in the transformation zone. 
Recent work in our laboratory, which uses the same data set described in this paper, have 
shown that HSIL sites were characterized by significantly lower values of the A and Coll, and 
significantly higher values of Hb compared to the non-HSIL sites. The AUC, sensitivity and 
specificity of 0.65, 78%, and 57% were achieved on the basis of A parameter. Combination of 
Coll and Hb parameters produced similar AUC, sensitivity and specificity (0.68, 78% and 
67%, respectivelly) [29] 
We find that after per-patient normalization, HSIL sites are characterized by significantly 
lower values of the A parameter and significantly higher values of α, Hb, and bvr compared to 
non-HSIL sites. AUC, sensitivity and specificity of 0.84, 89% and 79%, respectively, were 
achieved. The positive and negative predictive values were 48% and 97%, respectively. The 
normalized  A  parameter was the most diagnostic and the only parameter retained in the 
logistic regression algorithm. The box plots of normalized A, α, bvr, and Hb which have 
statistically significant differences between non-HSIL and HSIL sites, and Coll which has no 
statistically significant difference between non-HSIL and HSIL are shown in Figs. 1(a)-1(e), 
respectively, and the ROC plot based on the normalized A parameter is shown in Fig. 1(f). 
CNSQ sites are significantly different from both non-HSIL and HSIL sites for all parameters 
shown. 
3.4. Effect of glandular content on spectroscopic parameters 
Because the glandular content varies within the transformation zone, we also investigated the 
effect of gland-to-stroma ratio on the diagnostic normalized spectroscopy parameters. While 
all HSIL can be differentiated from non-GS sites by the lower values of A and Coll and higher 
values of Hb, α and bvr, only two parameters, A and α, were significantly different between 
HSIL sites and GS sites based on the Wilcoxon Rank Sum test. Figure 2 shows box plots of 
the A and α parameters. The A parameter was significantly different between GS and non-GS 
sites, while α was not significantly different. We also developed logistic regression models to 
differentiate all HSIL from non-GS and GS sites. In both cases, A alone provided the best 
discrimination between the two sites and the impact of other parameters was negligible. AUC, 
sensitivity, and specificity for differentiating all HSIL from non-GS were 0.84, 89% and 79%, 
respectively. AUC, sensitivity, and specificity for differentiating all HSIL from GS sites were 
0.82, 89% and 70%, respectively. 
 
Fig. 2. Discrimination of HSIL from GS and non-GS sites. Box plots of normalized (a) A 
parameter and (b) α. 
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Both disease and normal variations in microscopic anatomy are significant sources of 
spectroscopic contrast in clinically obtained tissue spectra. In order to properly evaluate the 
accuracy of disease detection, spectroscopic data must therefore be analyzed within the 
appropriate anatomical context. This study specifically focuses on differentiating HSILs from 
non-HSILs among clinically suspicious sites, the majority of which are found within the 
transformation zone. We find that after normalization by an internal standard, the A parameter 
alone provided the best diagnostic performance in differentiating HSIL from non-HSIL sites. 
AUC, sensitivity and specificity of 0.84, 89% and 79%, respectively, were achieved. Positive 
and negative predictive values were 48% and 97%, respectively. The high negative predictive 
value suggests that this technique may be useful for reducing the number of unnecessary 
biopsies. Even though the spectroscopy parameters including A parameter are affected by 
glandular content, the A parameter was the most diagnostic parameter in the discrimination of 
HSIL from both GS and non-GS sites. 
In our study HSIL sites exhibit significantly lower values of A parameter relative to the 
non-HSIL sites. This result is in agreement with results from similar studies in the literature. 
In a study of 161 patients, Mirabal et al. [10] found that there is a gradual decrease in mean 
reflectance intensity as the severity of dysplasia increases. In studies by Nordstrom et al. [5], 
and Huh et al. [8], reflectance was found to differentiate between HSIL and normal sites in 
the transformation zone (squamous metaplasia), while fluorescence did not yield significant 
differences. For both studies it is not known whether the differences in reflectance spectra 
were due to a higher hemoglobin concentration, lower scattering, or a combination of the two 
effects. Furthermore, our study cannot be directly compared to these two studies, as our study 
compares HSIL to all clinically suspicious non-HSIL sites, including the LSIL sites, while 
their studies report LSIL and squamous metaplasia sites separately. Georgakoudi et al. [9]. 
also report lower reduced scattering coefficient (similar to A parameter) for distinguishing 
SILs from biopsied non-SILs. However, we cannot directly compare their findings to those of 
this study as they did not discriminate HSIL from non-HSIL. Finally, the findings of the 
follow-up clinical in vivo study conducted with the Quantitative Spectroscopy Imaging 
system (manuscript in preparation) were consistent with the findings of our study. This study 
also observed that after normalization by an internal standard, the A parameter alone provided 
the best diagnostic performance in differentiating HSIL from non-HSIL sites [33]. 
The lower value of the A parameter for HSIL sites compared to non-HSIL sites is also 
physically justified. Arifler et al. [34] used Monte Carlo modeling of cervical tissue to show 
that the smaller stromal reduced scattering coefficient is the major cause for decreased 
reflectance intensity of HSIL compared to normal squamous tissue. Degradation of stromal 
collagen by matrix metalloproteinase activity [19,20] is the likely explanation for the lower 
value of A parameter for HSIL sites compared to non-HSIL sites. 
We also observe higher hemoglobin concentration of HSIL sites relative to the non-HSIL 
sites. Higher hemoglobin concentration in HSIL sites compared to other tissue types has been 
noted by Chang et al. [4] Additionally, Marin et al. [2] report that hemoglobin features of the 
reflectance tissue spectra are more prominent in abnormal tissue compared to normal 
squamous tissue. However, studies that considered diagnosing HSIL within clinically 
suspicious sites, such as Georgakoudi et al. [9], as well as Mourant et al. [11] reported no 
significant change in the hemoglobin concentration between HSIL and non-HSILs. 
Our finding of higher hemoglobin oxygenation for HSIL sites compared to non-HSIL 
within the clinically suspicious sites is consistent with the results of a study by Mourant et al. 
[11] which also looked at the difference between HSIL and clinically suspicious non-HSIL 
sites, 90% of which were found in the transformation zone. The source of higher hemoglobin 
oxygenation for HSIL sites is not well understood and needs further investigation. 
We find that the effective blood vessel radius is increased for HSIL sites compared to non-
HSIL sites. This may be due to the presence of dilated atypical blood vessels associated with 
precancerous and cancerous changes [35]. 
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observation is consistent with decreased collagen fluorescence due to degradation of collagen 
matrix, increased NADH fluorescence due to changes in cellular metabolism, or a 
combination of both. The increase in epithelial thickness is not a source of this feature, since 
there was no significant difference in measured epithelial thickness between HSIL and non-
HSIL sites in our study. Increased NADH contribution of SILs compared to non-SILs within 
the transformation zone has been observed by Georgakoudi et al. [9] Chang et al. [4] report a 
decreased stromal collagen contribution; however, their study included clinically normal 
squamous sites. Studies by Nordstrom [5], and Huh [8], which utilize 340 nm fluorescence, 
reported no significant differences between HSIL and normal sites in the transformation zone 
(squamous metaplasia). A study of Ramanujam et al. reported that 340 nm excitation HSIL 
sites could not be differentiated from non-HSIL sites in the transformation zone (cervical 
intraepithelial neoplasia 2/3 (equivalent to HSIL) vs. squamous metaplasia). 
We found that normalization of the spectroscopy parameters enhanced the contrast 
between HSIL and non-HSIL sites. Normalization may reduce spectroscopic variations due to 
intrinsic patient-to-patient variations associated with age, hormonal contraception, and 
menopausal status. Furthermore, it may account for differences caused by the time-dependent 
effect of acetic acid on tissue scattering and absorption. The vasoconstrictive and light 
scattering effects of acetic acid [35,36] may affect the extracted hemoglobin concentration, 
effective blood vessel radius, and also the scattering parameters. Recent work in our 
laboratory, which uses the same data set described in this paper, showed that without 
parameter normalization, HSIL sites could be differentiated from non-HSIL with AUC, 
sensitivity, and specificity of only 0.68, 78% and 67%, respectively [29]. In the present study, 
we found that parameter normalization resulted in substantial improvements performance 
metrics, as reported above. However, we point out that per-patient normalization of Coll 
parameter has decreased the ability of this parameter to differentiate between non-HSIL and 
HSIL sites. Further investigation is required to determine the best strategy for fluorescence 
per-patient normalization. 
The finding that only the A  parameter has diagnostic importance suggests that a 
significantly simpler, faster, and less expensive instrument which measures tissue scattering 
using one wavelength may be all that is required to reliably detect cervical disease. The 
limitation of our study is a relatively small number of patients. If the results of our study are 
further confirmed in the ongoing larger imaging clinical study, our laboratory will design a 
simplified instrument for detecting cervical dysplasia and investigate how effective this 
approach is in improving the accuracy of cervical dysplasia detection. In developed countries, 
this simple instrument could be used as an adjunct to colposcopy to reduce the number of 
unnecessary biopsies. However, the greatest impact of this simple and relatively inexpensive 
instrument would be on cervical cancer diagnosis in developing countries, where the lack of 
medical infrastructure precludes cytology-based cervical cancer screening program. In these 
settings, the common mode of cervical cancer screening is by visual inspection after 
application of acetic acid (VIA) followed by immediate treatment of suspicious lesions. VIA 
has a significant false positive rate. The simple spectroscopic instrument could be used as an 
adjunct to VIA to improve accuracy in the diagnosis of cervical cancer and its precursors. 
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